Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Skjalg Bruheim

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamideSkjalg Bruheim, Yaguang Xi, Jingfang Ju, et al.
Anticancer Research|September 12, 2013
Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenograftsSkjalg Bruheim, Marit Liland Sandvold, Gunhild M Mælandsmo, et al.
Experimental Cell Research|January 10, 2016
The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivoTorunn Wendel, Yan Zhen, Zenhe Suo, et al.
Receptors & Channels|August 15, 2003
Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and GsSkjalg Bruheim, Kurt A Krobert, Kjetil Wessel Andressen, et al.
Pathology Oncology Research : POR|September 28, 2004
Human osteosarcoma xenografts and their sensitivity to chemotherapySkjalg Bruheim, Oyvind S Bruland, Knut Breistol, et al.
International Journal of Cancer|January 13, 2011
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenograftsSkjalg Bruheim, Alexandr Kristian, Toshimitsu Uenaka, et al.
Plos One|February 25, 2011
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR arrayBin Wang, Paul Howel, Skjalg Bruheim, et al.
European Journal of Medicinal Chemistry|May 13, 2009
Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in ratsSverre Høyem, Skjalg Bruheim, Gunhild Maelandsmo, et al.
Bioconjugate Chemistry|November 13, 2010
Radiosynthesis and biodistribution of a prosthetic group (¹⁸F-FENMA) conjugated to cyclic RGD peptidesDag Erlend Olberg, Alan Cuthbertson, Magne Solbakken, et al.
Cancer Genomics & Proteomics|March 25, 2008
CDH11 expression is associated with survival in patients with osteosarcomaGo Nakajima, Ana Patino-Garcia, Skjalg Bruheim, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamideSkjalg Bruheim, Yaguang Xi, Jingfang Ju, et al.
Anticancer Research|September 12, 2013
Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenograftsSkjalg Bruheim, Marit Liland Sandvold, Gunhild M Mælandsmo, et al.
Experimental Cell Research|January 10, 2016
The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivoTorunn Wendel, Yan Zhen, Zenhe Suo, et al.
Receptors & Channels|August 15, 2003
Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and GsSkjalg Bruheim, Kurt A Krobert, Kjetil Wessel Andressen, et al.
Pathology Oncology Research : POR|September 28, 2004
Human osteosarcoma xenografts and their sensitivity to chemotherapySkjalg Bruheim, Oyvind S Bruland, Knut Breistol, et al.
International Journal of Cancer|January 13, 2011
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenograftsSkjalg Bruheim, Alexandr Kristian, Toshimitsu Uenaka, et al.
Plos One|February 25, 2011
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR arrayBin Wang, Paul Howel, Skjalg Bruheim, et al.
European Journal of Medicinal Chemistry|May 13, 2009
Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in ratsSverre Høyem, Skjalg Bruheim, Gunhild Maelandsmo, et al.
Bioconjugate Chemistry|November 13, 2010
Radiosynthesis and biodistribution of a prosthetic group (¹⁸F-FENMA) conjugated to cyclic RGD peptidesDag Erlend Olberg, Alan Cuthbertson, Magne Solbakken, et al.
Cancer Genomics & Proteomics|March 25, 2008
CDH11 expression is associated with survival in patients with osteosarcomaGo Nakajima, Ana Patino-Garcia, Skjalg Bruheim, et al.
Pageof 2